These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11784375)

  • 1. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine.
    Kochen S; Giagante B; Oddo S
    Eur J Neurol; 2002 Jan; 9(1):41-7. PubMed ID: 11784375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG changes and seizure exacerbation in young children treated with carbamazepine.
    Talwar D; Arora MS; Sher PK
    Epilepsia; 1994; 35(6):1154-9. PubMed ID: 7988504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of epileptic seizures by carbamazepine: report of 10 cases.
    Parmeggiani A; Fraticelli E; Rossi PG
    Seizure; 1998 Dec; 7(6):479-83. PubMed ID: 9888492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological characterization of spontaneous and carbamazepine-induced epileptic negative myoclonus in benign childhood epilepsy with centro-temporal spikes.
    Parmeggiani L; Seri S; Bonanni P; Guerrini R
    Clin Neurophysiol; 2004 Jan; 115(1):50-8. PubMed ID: 14706468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epileptic negative myoclonus induced by carbamazepine in a child with BECTS. Benign childhood epilepsy with centrotemporal spikes.
    Nanba Y; Maegaki Y
    Pediatr Neurol; 1999 Sep; 21(3):664-7. PubMed ID: 10513696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence on ictal seizure semiology of rapid withdrawal of carbamazepine and valproate in monotherapy.
    Zhou D; Wang Y; Hopp P; Kerling F; Kirchner A; Pauli E; Stefan H
    Epilepsia; 2002 Apr; 43(4):386-93. PubMed ID: 11952768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized onset seizures with focal evolution (GOFE) - A unique seizure type in the setting of generalized epilepsy.
    Linane A; Lagrange AH; Fu C; Abou-Khalil B
    Epilepsy Behav; 2016 Jan; 54():20-9. PubMed ID: 26619379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizure exacerbation and developmental regression with carbamazepine.
    Prasad AN; Stefanelli M; Nagarajan L
    Can J Neurol Sci; 1998 Nov; 25(4):287-94. PubMed ID: 9827229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep.
    Hennessy MJ; Tighe MG; Binnie CD; Nashef L
    Neurology; 2001 Nov; 57(9):1650-4. PubMed ID: 11706106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of seizures activity during rapid withdrawal of lamotrigine.
    Wang-Tilz Y; Tilz C; Wang B; Pauli E; Koebnick C; Stefan H
    Eur J Neurol; 2005 Apr; 12(4):280-8. PubMed ID: 15804245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exacerbation of seizures by carbamazepine in four children with symptomatic localization related epilepsy].
    Miyamoto A; Takahashi S; Oki J; Itoh J; Cho K
    No To Hattatsu; 1995 Jan; 27(1):23-8. PubMed ID: 7873247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children.
    Sobaniec W; Kułak W; Strzelecka J; Smigielska-Kuzia J; Boćkowski L
    Pharmacol Rep; 2005; 57(5):646-53. PubMed ID: 16227648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome.
    Kikumoto K; Yoshinaga H; Oka M; Ito M; Endoh F; Akiyama T; Ohtsuka Y
    Epileptic Disord; 2006 Mar; 8(1):53-6. PubMed ID: 16567326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine.
    Dhuna A; Pascual-Leone A; Talwar D
    Epilepsia; 1991; 32(2):275-8. PubMed ID: 1900790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aggravation of epilepsy by valproate sodium in a child with cryptogenic localization-related epilepsy].
    Watanabe Y; Watanabe K; Ohtsuka Y
    No To Hattatsu; 2011 Jan; 43(1):51-5. PubMed ID: 21400933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine-induced seizures: a case report and review of the literature.
    Gansaeuer M; Alsaadi TM
    Clin Electroencephalogr; 2002 Oct; 33(4):174-7. PubMed ID: 12449849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy.
    Konishi T; Naganuma Y; Hongou K; Murakami M; Yamatani M; Okada T
    Clin Electroencephalogr; 1995 Apr; 26(2):113-9. PubMed ID: 7781190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine-exacerbated epilepsy in children and adolescents.
    Horn CS; Ater SB; Hurst DL
    Pediatr Neurol; 1986; 2(6):340-5. PubMed ID: 3508708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of benign focal epilepsies in children: when and how should be treated?
    Oguni H
    Brain Dev; 2011 Mar; 33(3):207-12. PubMed ID: 21095081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.